FDA panel expected to review data about Pfizer boosters Friday

ABC NEWS– In a critical meeting Friday, an FDA panel is expected to review data about Pfizer’s booster shots. The Biden administration had hoped to make the booster shots available to everyone starting Monday, but a CDC panel won’t meet until later next week to make its recommendation on the shots.

ABC’s Elizabeth Schulze has more from Washington.

Categories: National News